Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: Belgium Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20191
20202
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH2
Novartis Pharmaceuticals2
Bristol-Myers Squibb1
Imcyse SA1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases7
Immune System Diseases3
Arthritis, Rheumatoid2
Joint Diseases2
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating2
Rheumatic Diseases2
Arthritis1
Connective Tissue Diseases1
Demyelinating Diseases1
Diabetes Mellitus, Type 11

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.